IFP Advisors
TNGX icon

IFP Advisors’s Tango Therapeutics TNGX Stock Holding History

IFP Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.24K Hold
210
– – ﹤0.01% 3788
2026
Q2 		$6.56K Sell
210
-23
-10% -$569 ﹤0.01% 3623
2026
Q1 		$4.87K Hold
233
– – ﹤0.01% 3541
2025
Q4 		$2.06K Hold
233
– – ﹤0.01% 3821
2025
Q3 		$1.96K Hold
233
– – ﹤0.01% 3703
2025
Q2 		$1.19K Buy
+233
New +$576 ﹤0.01% 4157
2024
Q4 		– Hold
0
– – – 4164

Other funds holding TNGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

IFP Advisors's TNGX Position: Q3 2026 in Review

IFP Advisors held its Tango Therapeutics (TNGX) position steady in Q3 2026 at 210 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #3788.

IFP Advisors first reported a position in TNGX in Q2 2025 and has held it in 6 quarters since. The position peaked at $6.56K in Q2 2026. 97 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • IFP Advisors held 210 shares of Tango Therapeutics worth $5.24K as of Q3 2026.
  • IFP Advisors left its Tango Therapeutics share count unchanged in Q3 2026.
  • Tango Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3788 holding.
  • IFP Advisors first reported a position in Tango Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • IFP Advisors's Tango Therapeutics position peaked at $6.56K in Q2 2026.
  • 97 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.